Anima Biotech

Anima Biotech is a pioneering Tech.Bio company revolutionizing drug discovery at the intersection of mRNA biology and Artificial Intelligence. Through its innovative mRNA Lightning platform, Anima Biotech is dedicated to the discovery of small molecule mRNA drugs and novel mRNA biology targets. With over a decade of expertise in mRNA biology, the company integrates advanced mRNA understanding with AI imaging technologies to visualize the complete lifecycle of mRNA within cells, decoding the mRNA biology underlying various diseases.

Located at 75 Claremont Rd, Bernardsville, New Jersey 07924, US, Anima Biotech utilizes millions of images from healthy and diseased cells to train disease-specific mRNA image analysis neural networks. These networks recognize disease signatures and mRNA biology pathways that drive disease phenotypes. The company's tera-scale mRNA biology lab conducts high-content screening from an optimized library of mRNA modulators, sending images to the mRNA image neural network to identify active compounds that visually alter the mRNA biology signature. The MOAi technology, an mRNA biology large language model, and the Lightning co-pilot further enhance this process, elucidating mechanisms of action and molecular targets.

Anima Biotech's mRNA Lightning platform has been validated through strategic collaborations with industry leaders such as Lilly, Takeda, and AbbVie across diverse therapeutic areas. This validation supports a robust pipeline of 20 drug discovery programs. Anima Biotech is poised to continue its leadership in biotechnology research and development. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.